Inc .

share communities

vascular support

Patent and Trademark Office.

role share

ev3 Inc. Prices Initial Public Offering of Common Stock

announced today the
pricing of its initial public offering of 11,765,000 shares of its common
stock at a price of $14. Banc of America Securities LLC
Attn: Equity Capital Markets Prospectus Department
800 Nicollet Mall 100 West 33rd Street
Minneapolis, Minnesota 55402 New York, New York 10001
Telephone: (612) 303-6220 Telephone: (646) 733-4166

Bear, Stearns + Co.

giving opportunity

The plan provides for the exercise and sale of up to
14 ,000 shares per month.

opportunity experience

The plan replaces a similar plan entered into last year, which expired earlier
this month.

share condition

, Edwards Lifesciences
Corporation (NYSE: EW), a global leader in products and technologies to treat
advanced cardiovascular disease, today announced that its chairman and chief
executive officer, Michael A.

common opportunity

00 per share. FloTrac is a trademark of Edwards
Lifesciences Corporation.

These groups, communities, or meeting places provide an opportunity for people with a common experience (such as a condition or disease, or a care-giving role) to share their concerns, and to seek and offer information and advice.

seek disorders

Transactions under this plan
will be disclosed publicly through Form 144 and Form 4 filings with the U. Patent and Trademark Office.

condition disease

is a global medical device company focused on endovascular
technologies for the minimally invasive treatment of vascular diseases and
disorders.

Edwards Lifesciences ' Chairman and CEO Adopts New 10b5-1 Stock Trading Plan

About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease
treatments, is the number-one heart valve company in the world and the global
leader in acute hemodynamic monitoring.edwards.

advice share

Rule 10b5-1 allows corporate insiders to adopt written, pre-arranged stock
trading plans to buy or sell a specified number of shares of company stock.

lymphedema common

Edwards Lifesciences, Edwards, Carpentier -Edwards, Cosgrove-Edwards,
Fogarty, PERIMOUNT and Swan-Ganz are trademarks of Edwards Lifesciences
Corporation and are registered in the U.

lymphedema concerns

Inc.com/InvestorRelations.
The stock trading plan was adopted in accordance with SEC guidelines. The
company's global brands, which are sold in approximately 100 countries,
include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent,
PERIMOUNT and Swan-Ganz.

experience groups

and one of its stockholders
have granted to the underwriters a 30-day option to purchase up to an
additional 1,764,750 shares of common stock at the initial public offering
price to cover over-allotments, if any.

groups provide

Copies of the final prospectus relating to the offering may be obtained from:

Piper Jaffray + Co.

vascular offer

Mussallem, has adopted a pre-arranged stock
trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934.

diseases meeting

Securities and Exchange Commission (SEC).edwards.

lymphedema cardiovascular

IRVINE, Calif.
Insiders may adopt such plans when they are not in possession of material,
inside information in order to gradually change their investment portfolio to
minimize any market effect of stock sales or purchases by spreading them out
over an extended period of time , and to avoid concerns about initiating stock
transactions while in possession of material, non-public information.com.

giving role

Thomas Weisel Partners LLC
383 Madison Avenue One Montgomery Street, Suite 3700
New York, New York 10179 San Francisco, California 94104
Telephone: (631) 274-8321 Telephone: (415) 364-2500

ev3 Inc.
LifeStent is a trademark of Edwards Lifesciences AG and is registered in the
U.

groups support

ev3 Inc.
Mussallem presently is in full compliance with the company's stock
ownership guidelines for its executive officers and intends to remain in
compliance throughout this stock trading plan.S.,
Edwards focuses on specific cardiovascular opportunities including heart valve
disease, peripheral vascular disease and critical care technologies.

these advice

This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. The Form 4 filings will also be
posted on Edwards' investor relations Web site at
http://www. Additional company information can be found at
http://www.

diseases condition

The plan will provide a vehicle for Mussallem to exercise Edwards
stock options , including options due to expire in 2007 and 2008, to support
his strategy for philanthropic giving , asset diversification and retirement of
a home mortgage loan.

condition lymphedema

PLYMOUTH, Minn. and Thomas Weisel Partners LLC, acting as co-managers.

Headquartered in Irvine, Calif.S.

places opportunity

, ev3 Inc.
The underwriters of the offering are Piper Jaffray + Co.

concerns provide

and Banc of
America Securities LLC, acting as joint book-running managers, and Bear,
Stearns + Co.